About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

UNKNOWNPhase 4

OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP

Multicentre Randomised Controlled Trial of Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on Continuous Positive Airways Pressure

NCT02140580•Menzies Institute for Medical Research

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Bronchopulmonary Dysplasia

Interventions

Minimally invasive surfactant therapy

Continuation on CPAP

Locations

16

United States

Locations (16)

Yale-New Haven Children's Hospital

New Haven, Connecticut, United States

Kapi'olani Medical Center for Women and Children

Honolulu, Hawaii, United States

NorthShore Health University HealthSystem Evanston Hospital

Evanston, Illinois, United States

Cooper University Hospital

Camden, New Jersey, United States

West Virginia University Hospital

Morgantown, West Virginia, United States

Royal Hobart Hospital

Hobart, Tasmania, Australia

Key Dates

Start Date

December 1, 2011

Primary Completion Date

May 1, 2020

Completion Date

June 1, 2022

Last Updated

May 1, 2020

Related Studies

RECRUITINGPhase 2

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

NCT06925360

Bronchopulmonary Dysplasia

Reversibility of Bronchial Obstruction in Children Born Preterm

NCT06110481

Bronchopulmonary DysplasiaChronic Lung Disease of Prematurity+5 more

The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)

NCT06342752

Bronchopulmonary Dysplasia

Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study

NCT06821776

Bronchopulmonary DysplasiaFeeding Intolerance

Comparison of INRECSURE and LISA in Preterm Neonates With RDS

NCT05711966

Respiratory Distress SyndromeBronchopulmonary Dysplasia

Active Not Recruiting

Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia

NCT01632475

Bronchopulmonary Dysplasia

View all related studies

Sponsors

Lead Sponsor

Menzies Institute for Medical Research

Collaborators

Royal Hobart Hospital
Royal Women's Hospital, Melbourne, Australia
Endeavor Health
Monash Medical Centre
Mercy Hospital for Women, Australia
Auckland City Hospital
Middlemore Hospital, New Zealand
Zekai Tahir Burak Women's Health Research and Education Hospital
Kapiolani Medical Center For Women & Children
The Cooper Health System
Yale University
West Virginia University Hospital
Uludag University
Ziv Medical Center
Bnai Zion Medical Center
University Medical Centre Ljubljana
Dunedin Hospital
Kanuni Sultan Suleyman Training and Research Hospital
University Medical Center Groningen
University of Southern California

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions